Cellarity Stock
HealthTechLooking to sell Cellarity stock or options?
Cellarity is a developer of a biomedical platform aimed at digitizing molecular information within cells to understand their behavior in both health and disease. The company's platform leverages single-cell technologies and machine learning to digitize and quantify cellular behaviors, uncover the network dynamics that drive these behaviors, and develop medicines capable of directing them. This approach enables other companies to enhance the success rate and speed of drug discovery.
Investors Include:
Hanwha Impact, Ahren Innovation Capital, BlackRock, Kyowa Kirin, The Baupost Group, Flagship Pioneering, Hercules Capital, Pictet, Jameel Investment Management Company.